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Abstract We report a rapid and sensitive colorimetric approach
to quantitate the amount of glucose transporters exposed at the
surface of intact cells, using L6 muscle cells expressing GLUT4
containing an exofacial myc epitope. Unstimulated cells exposed
to the surface 5 fmol GLUT4myc per mg protein. This value
increased to 10 fmol/mg protein in response to insulin as
2-deoxyglucose (10 WM) uptake doubled. The results are
substantiated by immunofluorescent detection of GLUT4myc in
unpermeabilized cells and by subcellular fractionation. We
further show that wortmannin and the cytoskeleton disruptors
cytochalasin D and latrunculin B completely blocked these
insulin effects. The rapid quantitative assay described here could
be of high value to study insulin signals and to screen for
potential anti-diabetic drugs.
z 1998 Federation of European Biochemical Societies.
Key words: Glucose transport; Cell surface;
Plasma membrane; Actin cytoskeleton; Latrunculin B
1. Introduction
Insulin rapidly stimulates the rate of glucose uptake into the
major glucose consuming tissues, fat and muscle. The insulin-
stimulated glucose uptake mainly results from the transloca-
tion of GLUT4 from an intracellular storage pool to the
plasma membrane. Several subcellular fractionation studies
have demonstrated an increase in GLUT4 in a plasma mem-
brane-enriched fraction in response to insulin, which cannot
be accounted for by the new synthesis of glucose transporter
proteins [1^3], but rather by the redistribution of GLUT4
from an internal pool to the plasma membrane [4^7]. In
type 2 diabetes mellitus, fat cells and muscle ¢bers appear
to be insensitive to the hormone [8^10], a defect that has
been associated with impaired GLUT4 translocation [11,12].
To date, the exact molecular mechanism by which insulin
induces the translocation of GLUT4 to the plasma membrane
is not fully understood, although it is known that stimulation
of glucose uptake and GLUT4 translocation require the acti-
vation of phosphatidylinositide 3-kinase [13,14] and the exist-
ence of an intact actin network [15]. An understanding of the
molecular mechanisms of insulin-stimulated glucose transport
might provide insights into the insensitivity of target cells in
type 2 diabetes.
The L6 muscle cell line has been used to study skeletal
muscle glucose metabolism in response to acute insulin stim-
ulation [1,2,16]. Subcellular fractionation followed by immu-
noblotting as well as photoa⁄nity labeling followed by immu-
noprecipitation has demonstrated that the hormone causes
rapid translocation of GLUT4 to the plasma membrane
[16^18]. These manipulations are lengthy and could introduce
factors which may lead to inaccuracy. An ideal method should
allow one to immunologically detect GLUT4 on the surface
with an anti-exofacial antibody speci¢c for GLUT4.
We report the development of a simple method for the
rapid detection of GLUT4 translocation in cells in culture
of high sensitivity, which allows for the accurate calculation
of the number of molecules of GLUT4 at the cell surface. We
use this method to demonstrate a requirement for an intact
cytoskeletal network in the translocation of GLUT4.
2. Materials and methods
2.1. Materials
o-Phenylenediamine dihydrochloride (OPD) and peroxidase-
coupled donkey anti-mouse IgG was obtained from Sigma (St. Louis,
MO). C-myc peptide and monoclonal antibody 9E10 were purchased
from Genosys (Woodland, TX), and Santa Cruz (Santa Cruz, CA)
respectively. Cy3-conjugated goat anti-mouse IgG was obtained from
Jackson ImmunoResearch (West Grove, PA). Antifade kit was pur-
chased from Molecular Probes (Leiden, The Netherlands).
2.2. Construction of L6 cells expressing c-myc epitope-tagged GLUT4
(GLUT4myc)
GLUT4myc cDNA was constructed by inserting the human c-myc
epitope (14 amino acids) into the ¢rst ectodomain of GLUT4, as
described [19]. The epitope does not a¡ect GLUT4 activity [19].
GLUT4myc cDNA was subcloned into the mammalian expression
vector pCXN (pCXN-GLUT4myc) [20]. L6 myoblasts were trans-
fected with pCXN-GLUT4myc and pSV2-bsr, a blasticidin S deami-
nase expression plasmid, and selected with blasticidin S hydrochloride
(Funakoshi, Tokyo).
2.3. Cell culture
L6-GLUT4myc myoblasts in cell monolayers were maintained in
K-MEM supplemented with 10% fetal bovine serum in a humidi¢ed
atmosphere containing 10% CO2 and 90% air at 37‡C. Cells were
grown in 15 cm2 dishes for subcellular fractionation experiments, in
12 or 24 well plates for glucose uptake and immunocolorimetric as-
says, and on glass coverslips for immunocytochemistry. Prior to ex-
periments, cells were incubated with serum-free K-MEM supple-
mented with 25 mM glucose for 5 h.
2.4. 2-Deoxy-[3H]D-glucose uptake
Hexose uptake was measured at room temperature for 5 min in
transport bu¡er containing: 20 mM HEPES, pH 7.4 and 10 WM
2-deoxy-[3H]D-glucose (1 mCi/ml) as described previously [2]. Cellular
protein content was measured by the bicinchoninic acid method [21].
2.5. Indirect immuno£uorescence
Quiescent L6-GLUT4myc cells grown on glass coverslips were
treated as described in each experiment, then rinsed once with PBS,
¢xed with 3% paraformaldehyde in PBS for 3 min at room temper-
ature, and neutralized with 1% glycine in PBS at 4‡C for 10 min. The
cells were incubated with PBS containing 10% goat serum and 3%
BSA at 4‡C for at least 30 min. Primary antibody (anti-c-myc 9E10)
was added at a dilution of 1:100 and maintained at 4‡C for 30 min.
The cells were extensively washed with cold PBS before introducing
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the secondary antibody (Cy3-IgG, 1:1000) for 30 min at 4‡C. The
cells were washed, then mounted and immediately examined by im-
muno£uorescence microscopy.
2.6. Subcellular fractionation and immunoblotting
Membrane preparations were performed as described previously for
wild type L6 cells [22]. Equal amounts of membrane proteins were
analyzed by SDS-PAGE and electrotransferred onto PVDF ¢lters as
described [22]. Immunoreactive bands were visualized using either
HRP-conjugated sheep anti-mouse IgG for monoclonal antibodies
or HRP-conjugated goat anti-rabbit IgG for polyclonal antibodies,
with the enhanced chemiluminescence (ECL) detection technique. De-
veloped ¢lms were scanned and quantitated using NIH software.
2.7. Colorimetric assay of surface GLUT4myc
Quiescent L6-GLUT4myc cells treated as indicated were washed
once with PBS, ¢xed in 3% paraformaldehyde in PBS for 3 min at
room temperature, and the ¢xative was immediately neutralized by
incubation with 1% glycine in PBS at 4‡C for 10 min. The cells were
blocked with 10% goat serum and 3% BSA in PBS at 4‡C for at least
30 min. Primary antibody (anti-c-myc, 9E10) was then added into the
cultures at a dilution of 1:100 and maintained for 30 min at 4‡C. The
cells were extensively washed with PBS before introducing peroxidase-
conjugated rabbit anti-mouse IgG (1:1000). After 30 min at 4‡C, the
cells were extensively washed and 1 ml OPD reagent was added to
each well. The colorimetric reaction was stopped by addition of
0.25 ml of 3 N HCl for 10 min at room temperature. The supernatant
was collected and the optical absorbance was measured at 492 nm.
Standard curves were generated using either peroxidase conjugated
anti-mouse IgG alone or myc-tag peptide, as indicated. Myc-tag pep-
tide at various concentrations was coated onto 24-well plates as in-
dicated by incubation at 4‡C for 24 h then allowed to dry. The plates
were rinsed with PBS to move excess salt and the uncoated spaces
were blocked with 10% goat serum and 3% BSA.
2.8. Statistical analysis
Student’s t-test was used using Excel software.
3. Results
3.1. Hexose transport
Under basal conditions, L6-GLUT4myc myoblasts took up
glucose at a rate of 11.7 þ 0.6 pmol/min/mg protein. Insulin
signi¢cantly increased glucose uptake in a time-dependent
manner which peaked at 30 min (data not shown). At this
time, insulin stimulated glucose uptake to 22.6 þ 0.8 pmol/
min mg protein, representing a 193% rise over basal values
(P6 0.05) (Fig. 1a). The increase in glucose uptake was sig-
ni¢cantly decreased upon pre-treatment with 1 WM cytocha-
lasin D (P6 0.05, Fig. 1a), a drug which has been previously
reported to inhibit speci¢cally the increase in glucose trans-
port in L6 myotubes by disruption of actin ¢laments [15].
Furthermore, pre-treatment of cells with latrunculin B, a
structurally unrelated drug which inhibits polymerization of
actin ¢laments [23], resulted in a similar decrement of insulin-
stimulated glucose uptake (P6 0.05, Fig. 1a). The stimulation
by insulin was also signi¢cantly decreased (P6 0.05, Fig. 1a)
upon pre-treatment of the cells with wortmannin, a drug
which is known to block glucose uptake in muscle and fat
cells by inactivating phosphatidylinositol 3-kinase [13,14].
3.2. Subcellular fractionation
Immunoblot analysis of equal amounts of proteins of the
LDM and PM subcellular fractions showed a gain in GLUT4-
myc in isolated plasma membrane fractions from insulin
stimulated cells, and a concomitant decrease in the low den-
sity microsome fractions. Densitometric analysis of these blots
showed that the gain in GLUT4myc in the plasma membrane
and the loss in the internal membranes were statistically sig-
ni¢cant (P6 0.05) (Fig. 1b,c). Pre-treatment with cytochalasin
D or wortmannin signi¢cantly inhibited the insulin-mediated
increase of GLUT4myc in the plasma membrane fraction, and
prevented the insulin-dependent loss of GLUT4myc from the
light density microsomes (Fig. 1b, P6 0.05). Latrunculin B
behaved similarly to cytochalasin D in these subcellular frac-
tionation experiments (Fig. 1c, P6 0.05).
In one experiment, the immunoblots were also probed with
an anti-GLUT4 antibody. Two bands of comparable inten-
sities were detected: the endogenous GLUT4 and the
GLUT4myc which had a slower migration on SDS-PAGE.
The endogenous GLUT4 had relative values of 1.0, 0.6, 0.9,
and 1.1 in the LDM and 0.7, 0.9, 0.7 and 0.6 in the PM from
basal, insulin, cytochalasin D-insulin and wortmannin-insulin
treated cells. These values compare very closely with the rel-
ative values of GLUT4myc shown in Fig. 1b (1.0, 0.6, 1.1, 1.1,
and 0.7, 1.0, 0.7 and 0.6). Therefore, the transfected GLUT4-
myc behaves similarly to the endogenous transporter.
3.3. Immunostaining of intact cells
Non-permeabilized cells were reacted with anti-myc anti-
body (9E10) which was subsequently detected with Cy3-con-
jugated goat anti-mouse IgG as described in Section 2. In the
basal state, a low level of surface GLUT4 was detected (Fig.
2b), and the intensity of the staining increased upon insulin
stimulation (Fig. 2c). In contrast, insulin did not a¡ect the
background surface staining in wild type L6 cells (Fig. 2a).
Moreover, using this detection system it was demonstrated
that insulin did not increase the amount of GLUT4myc at
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Fig. 1. 2-Deoxy-[3H]D-glucose uptake in L6-GLUT4myc cells. Cells were serum-deprived for 5 h. In the last 2 h cells were treated with or with-
out cytochalasin D or latrunculin B, or for 20 min with or without wortmannin at the end of the 5 h period. The cells were then treated with
or without insulin (100 nM) for 30 min at 37‡C. a: Glucose uptake was measured at room temperature for 5 min in transport bu¡er as de-
scribed in Section 2. b, c: Detection of GLUT4 by immunoblotting of subcellular fractions of GLUT4myc cells.
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cell surface when L6-GLUT4myc cells were pre-treated with
wortmannin (Fig. 2d), cytochalasin D (Fig. 2e) or latrunculin
B (Fig. 2f).
3.4. Colorimetric quantitation of surface GLUT4myc
L6-GLUT4myc myoblasts were stimulated with insulin for
30 min at 37‡C. Anti-myc antibody 9E10 was added at vari-
ous dilutions and allowed to interact with the cells for 30 min
at 4‡C, followed by anti-mouse IgG conjugated to peroxidase
and then exposed to OPD as described in Section 2. The
reaction product increased linearly with the concentration of
the primary antibody to reach a maximum at a dilution of
1:100 (Fig. 3a). This dilution of 9E10 antibody was used for
all subsequent experiments. Fig. 3b,c shows the calibration
curves for the immunocolorimetric assay. In Fig. 3b, increas-
ing concentrations of myc peptide were coated onto 24 well
plates and any uncoated space was blocked with blocking
bu¡er as described in Section 2. The plates were then treated
with primary and secondary antibodies as described above for
intact cells. The optical absorbance was linear for up to 3 fmol.
In Fig. 3c, myc protein was omitted but increasing concen-
trations of peroxidase-coupled anti-mouse IgG were tested.
Optical absorbance was linear for up to 6 fmol IgG.
Table 1 quantitates the amount of GLUT4myc at the sur-
face of intact cells in response to insulin, as well as the e¡ects
of pre-treatments with wortmannin, cytochalasin D or latrun-
culin B, using the colorimetric method described above.
Under basal conditions, the optical density per well was
0.27 þ 0.04; insulin stimulation caused a signi¢cant increase
(P6 0.01) in optical absorbance to 0.53 þ 0.03. This increase
was fully blocked by pre-treatment with wortmannin
(0.22 þ 0.03), cytochalasin D (0.25 þ 0.03) or latrunculin B
(0.25 þ 0.03). To quantitate the amount of GLUT4myc trans-
located to the plasma membrane, the spectrophotometric
readings were referred to the calibration curves from Fig.
3b,c. Both standard curves yielded similar results, indicating
that the anti-myc antibody reacts with a close to 1:1 stoichi-
ometry to its antigen. In the basal state, the amount of cell
surface GLUT4myc was calculated to be about 5 fmol/mg
cellular protein. This value was approximately doubled by
the insulin treatment. Pre-treatment with wortmannin, cyto-
chalasin D or latrunculin B prevented the insulin e¡ect.
Finally, to calculate the percentage that the surface
GLUT4myc represents of the total cellular GLUT4myc, the
colorimetric assay of GLUT4myc was performed in intact
cells and in cells permeabilized with 0.1% Triton X-100. The
ratio of optical absorbance of intact:permeabilized cells was
1.0:2.6 in the basal state.
4. Discussion
Understanding the molecular mechanisms of insulin action
has been of major interest since the discovery, several decades
ago, that insulin stimulates glucose transport in vivo. Subcel-
lular fractionation, cell photolabeling coupled to immunopre-
cipitation and immuno£uorescence or immunoelectron mi-
croscopy have been used to detect translocation of the
GLUT4 glucose transporter to the cell surface [17,18,22,24].
All of these methods are laborious and su¡er from methodo-
logical inaccuracies. Subcellular fractionation is cumbersome
and produces membranes that are rarely pure; moreover,
quantitative recovery of all membrane compartments is di⁄-
cult or impossible. A⁄nity labeling of surface glucose trans-
porters followed by immunoprecipitation depends on the abil-
ity to obtain quantitative immunoprecipitation and recovery
upon SDS-PAGE. This technique results in the incorporation
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Table 1
Colorimetric detection of GLUT4myc on the surface of L6-GLUT4myc cells
Basal Insulin WM/Insulin CD/Insulin LB/Insulin
Optical absorbance (mean þ S.E.M.) 0.27 þ 0.04 0.52 þ 0.02 0.22 þ 0.03 0.25 þ 0.03 0.25 þ 0.03
Relative protein change (fmol/mg protein) calibrated using Fig. 3c 5.51 þ 0.82 10.82 þ 0.41 4.92 þ 0.62 5.45 þ 0.62 5.21 þ 0.63
Relative protein change (fmol/mg protein) calibrated using Fig. 3b 4.32 þ 0.66 9.51 þ 0.36 3.50 þ 0.46 4.32 þ 0.51 4.05 þ 0.49
L6-GLUT4myc cells pre-treated with or without wortmannin (WM), cytochalasin D (CD) or latrunculin B (LB) were incubated with 100 nM
insulin at 37‡C for 30 min. The cells were ¢xed and incubated with anti-myc antibody (9E10) as described in Section 2. Optical absorbance values
represent the mean þ S.E.M. of four separate experiments. The spectrophotometric readings were referred to the calibration curves from Fig. 3.
Fig. 2. Immunostaining of GLUT4 in non-permeabilized L6-GLUT4myc cells. Intact L6-GLUT4myc cells were stained with anti-myc mouse
IgG (9E10), and subsequently with Cy3 goat anti-mouse IgG to detect surface GLUT4 as described in Section 2. a: Wild type L6 cells. b: Un-
treated L6-GLUT4myc cells. c: L6-GLUT4myc cells stimulated with insulin. d: Wortmannin pre-treated L6-GLUT4myc cells stimulated with
insulin. e: Cytochalasin D pre-treated L6-GLUT4myc cells stimulated with insulin. f : Latrunculin B pre-treated L6-GLUT4myc cells stimulated
with insulin. All insulin (100 nM) treatments were for 30 min at 37‡C. The results shown are representive of ¢ve independent experiments.
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of about 1/10 000 of the label added, thus the signal to noise
ratio is low; moreover, the reactivity of the photolabel can
depend on the level of activity of the transporter [25] in addi-
tion to the amount of transporter exposed at the cell surface.
Immuno£uorescence detection does not distinguish the native
GLUT4 molecules incorporated into the cell membrane from
molecules in subplasmalemmal vesicles, and is not a quanti-
tative technique. Immunogold electron microscopy detects
antigens at the plasma membrane accurately, but has not
been successfully used in a quantitative fashion. None of the
above techniques is suitable for large numbers of experiments,
as would be required for screening of anti-diabetic drugs or of
agents interfering with insulin signaling or intracellular tra⁄c.
Therefore, the aim of the present study was to develop a fast
and quantitative approach to measure GLUT4 translocation
in intact cells. The method described here uses cells in culture
and does not require subsequent immunoprecipitation, SDS-
PAGE or use of radioactivity, as required by the photolabel-
ing technique. It does not require large amounts of cells nor
laborious subcellular fractionation. It is rapid, sensitive and
quantitative.
Introduction of a tag c-myc epitope (14 amino acids) into
the ¢rst exofacial loop of GLUT4 cDNA allows for the direct
detection of functional GLUT4 translocation to the plasma
membrane in intact cells. The e⁄cacy of the method was
compared with that of the conventionally used subcellular
fractionation and immuno£uorescence approaches. Virtually
similar e¡ects of insulin were detected by all three approaches,
and all three approaches showed that the insulin e¡ect was
obliterated by pre-treatment of the cells with wortmannin or
the cytoskeletal disassembling drug cytochalasin D. We have
recently reported that cytochalasin D prevents arrival of phos-
phatidylinositol 3-kinase to the GLUT4-containing vesicles of
3T3-L1 adipocytes [26]. Here we show that latrunculin B, a
drug that leads to disassembly of the cytoskeleton by a mech-
anism di¡erent from that of cytochalasin D, also prevents
GLUT4 translocation.
Previous studies have shown that in CHO cells or other
¢broblasts stably expressing heterologous GLUT4 [27,28], in-
sulin-stimulated translocation of the transfected GLUT4 was
not detectable by immunoblot analysis of subcellular frac-
tions, nor by immuno£uorescence microscopy [28]. However,
transfection of GLUT4myc allowed for detection of the exo-
facial epitope by 125I-labeled secondary antibody. By this ap-
proach, insulin-induced GLUT4myc translocation was ob-
served in CHO cells [19]. In the present study, GLUT4myc
was introduced into L6 insulin-sensitive muscle cells which
express endogenous GLUT4 as well as GLUT1 and
GLUT3. The amount of GLUT4myc expressed at the surface
of basal cells (5 fmol/mg protein) was in the range of that of
native GLUT4 (about 12 fmol/mg, see [16]). This discrete level
of expression of GLUT4myc likely allows for its correct local-
ization without saturation of the proteins determining its in-
tracellular sorting. The amount of hexose taken up during the
2-deoxyglucose uptake assay is a re£ection of uptake through
all transporters expressed in the cell.
GLUT4 translocation is a complex vesicular tra⁄c process
which includes fusion and docking steps. Herbst et al. [29]
showed previously that introduction of a peptide correspond-
ing to tyrosine-phosphorylated IRS-1 motifs into 3T3-L1 adi-
pocytes resulted in a signi¢cant increase in the translocation
of GLUT4 to the plasma membrane by immuno£uorescence
staining which mimicked the response to insulin. However, no
relative increase in the rate of glucose uptake was observed in
those cells. This led to the speculation that some stimulus may
bring GLUT4 vesicles to the plasma membrane (docking) but
is not su⁄cient to trigger fusion with the membrane. A con-
verse phenomenon was observed by others upon introducing
isoproterenol [30] or isoprenaline [25] to rat adipocytes where-
by the insulin-dependent gain in glucose transporter detected
in isolated plasma membrane was not changed while glucose
transport was decreased. It is therefore conceivable that im-
munostaining of isolated membranes or of permeabilized cells
cannot distinguish GLUT4 proteins docked on the plasma
membrane from those which are fully fused with it. The de-
tection of cell surface GLUT4 transporters achieved by the
approach described in this report detects GLUT4 fully incor-
porated into the plasma membrane.
In summary, we have developed a colorimetric assay for the
direct detection of GLUT4 translocation to the cell plasma
membrane in L6 muscle cells stably expressing GLUT4myc.
The results suggest that these transfected L6 cells possess the
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Fig. 3. Calibration of the reaction of anti-myc antibody (9E10) with myc epitope. a: L6GLUT4myc myoblasts incubated with 100 nM insulin
at 37‡C for 30 min were labelled with anti-myc antibody (9E10), and peroxidase-conjugated secondary sheep-anti mouse IgG as described in
Section 2. The reaction of OPD was measured at 492 nm. Results are the mean þ S.E.M., n = 3. b: In cell-free wells, c-myc peptide at various
concentrations was coated onto 24 well plates, blocked and reacted with anti-myc 9E10 antibody and peroxidase-conjugated secondary antibody
followed by OPD as described above. c: Direct incubation of various concentrations of peroxidase-conjugated sheep anti-mouse IgG with OPD
colorimetric reagent.
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basic machinery required for translocation of GLUT4myc
and, furthermore, the L6-GLUT4myc cell system appears to
be a sensitive and reliable in vitro model for studying the
molecular mechanisms of insulin action on GLUT4 translo-
cation, and for testing agents which may improve or impair
insulin action.
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